Cancer remains one of the most complex diseases. Scientists have learnt more in the last 2 decades than in the preceding centuries. A cancer patient today has more chance of survival than ever before. Will we ever be able to cure cancer? We are convinced we will. We are working towards a world in which cancer will be a preventable, chronic or curable disease.
Until then, we are applying ourselves unremittingly to helping cancer patients worldwide in their daily victories over the illness. They are facing a battle - small or great – every day, and at Janssen, it is our aim and privilege to support them in this.
We are facing great challenges in the search for new, innovative treatments. Cancer is also more than one illness. It is a very complex group of more than 100 illnesses. All forms of cancer behave differently and require a different treatment. Medical breakthroughs in a certain type of cancer cannot just be transferred to another type. However, our scientists are very enthusiastic about what they are learning and research is already making enormous progress. ‘There is a lot of hope for the future’, says Janine Arts, head of Oncology at Janssen R&D in Beerse. ‘For the first time, we can look at a tumor and see what is happening. It is not only about the cancer cells, but also the individual patient, his genetic makeup and the microenvironment of the tumor’.
We are working towards a world where cancer is a preventable, chronic or curable disease. We focus on the development of solutions that can extend and improve the life of patients.”
Despite great progress, we continue to look for revolutionary solutions.
At Janssen, we are striving for the development of new treatments for cancers for which there are currently only a few medical solutions available. In addition, we are focusing on the cancers that we know and understand best and for which we can achieve a major impact: different types of blood cancer, prostate and lung cancer. In the past four years, we have marketed five revolutionary treatments in Europe, and four more are in the final stages of development. Nevertheless, for Janssen, it doesn’t stop there. We want to go a step further and stop cancer before much damage has been done (this process is called cancer interception). Here, too, we and our research partners are making great progress.
But our efforts will not cease as long as there are patients who are in need of treatment. It is our mission to enable them to once more enjoy the meaningful moments of life. This is why we do it.
